Description
Anti-CD22 (pinatuzumab biosimilar) mAb
Target
CD22
Target Alias Names
CD22, SIGLEC2, BL-CAM, SIGLEC-2, Siglec2, SIGLEC2FLJ22814
Isotype/Mimetic
IgG1
Animal-Derived Biomaterials Used
None
Sequence Available
Yes
Original Discovery Method
Unknown
Antibody/Binder Origins
Unknown discovery source/method, In vitro recombinant expression